Ardsley Advisory Partners LP acquired a new position in shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 200,000 shares of the company’s stock, valued at approximately $1,248,000. Ardsley Advisory Partners LP owned 0.12% of Evolv Technologies at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in EVLV. Vanguard Group Inc. grew its position in shares of Evolv Technologies by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 9,402,716 shares of the company’s stock valued at $29,336,000 after acquiring an additional 477,124 shares during the period. Josh Arnold Investment Consultant LLC acquired a new position in shares of Evolv Technologies during the 1st quarter worth about $1,248,000. Key Colony Management LLC lifted its stake in Evolv Technologies by 2.0% in the 2nd quarter. Key Colony Management LLC now owns 3,105,000 shares of the company’s stock valued at $19,375,000 after buying an additional 62,000 shares in the last quarter. SCS Capital Management LLC purchased a new position in shares of Evolv Technologies in the first quarter valued at approximately $15,061,000. Finally, Nuveen LLC purchased a new position in Evolv Technologies in the 1st quarter valued at $977,000. Hedge funds and other institutional investors own 66.65% of the company’s stock.
Evolv Technologies Stock Up 2.3%
Evolv Technologies stock opened at $6.77 on Thursday. The company has a market capitalization of $1.18 billion, a PE ratio of -18.30 and a beta of 1.85. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.20 and a current ratio of 1.27. Evolv Technologies Holdings, Inc. has a fifty-two week low of $2.64 and a fifty-two week high of $8.91. The firm has a 50 day moving average price of $7.13 and a 200 day moving average price of $6.93.
Insider Buying and Selling at Evolv Technologies
In related news, Director Michael Ellenbogen sold 80,745 shares of the company’s stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of $8.26, for a total transaction of $666,953.70. Following the sale, the director directly owned 2,083,961 shares of the company’s stock, valued at $17,213,517.86. This represents a 3.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kevin M. Charlton purchased 15,000 shares of the firm’s stock in a transaction on Friday, November 21st. The stock was acquired at an average cost of $5.68 per share, with a total value of $85,200.00. Following the transaction, the director directly owned 44,081 shares in the company, valued at $250,380.08. This trade represents a 51.58% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have bought 61,300 shares of company stock worth $363,326 and have sold 440,745 shares worth $3,618,954. Corporate insiders own 11.30% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently weighed in on EVLV shares. Zacks Research upgraded shares of Evolv Technologies from a “strong sell” rating to a “hold” rating in a research report on Friday, October 17th. Weiss Ratings restated a “sell (d-)” rating on shares of Evolv Technologies in a research report on Wednesday, October 8th. Cantor Fitzgerald increased their price target on Evolv Technologies from $7.00 to $9.00 and gave the company an “overweight” rating in a report on Friday, August 15th. Lake Street Capital lifted their price objective on Evolv Technologies from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Finally, TD Cowen reissued a “buy” rating and set a $10.00 price objective on shares of Evolv Technologies in a research note on Friday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Evolv Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $9.13.
Read Our Latest Stock Report on Evolv Technologies
Evolv Technologies Company Profile
Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.
See Also
- Five stocks we like better than Evolv Technologies
- What is an Earnings Surprise?
- Market Momentum: 3 Stocks Poised for Major Breakouts
- What is the NASDAQ Stock Exchange?
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- Growth Stocks: What They Are, What They Are Not
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Evolv Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolv Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
